Davenport & Co’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.11M | Buy |
69,943
+24,807
| +55% | +$2.17M | 0.03% | 287 |
|
|
2025
Q1 | $3.08M | Buy |
45,136
+6,615
| +17% | +$452K | 0.02% | 388 |
|
|
2024
Q4 | $3M | Buy |
38,521
+873
| +2% | +$67.9K | 0.02% | 380 |
|
|
2024
Q3 | $2.52M | Buy |
37,648
+30,370
| +417% | +$2.04M | 0.01% | 420 |
|
|
2024
Q2 | $825K | Buy |
7,278
+274
| +4% | +$31.1K | 0.01% | 649 |
|
|
2024
Q1 | $971K | Buy |
7,004
+598
| +9% | +$82.9K | 0.01% | 611 |
|
|
2023
Q4 | $795K | Sell |
6,406
-588
| -8% | -$73K | 0.01% | 628 |
|
|
2023
Q3 | $653K | Sell |
6,994
-96
| -1% | -$8.96K | ﹤0.01% | 641 |
|
|
2023
Q2 | $911K | Buy |
7,090
+679
| +11% | +$87.3K | 0.01% | 570 |
|
|
2023
Q1 | $745K | Sell |
6,411
-9,840
| -61% | -$1.14M | 0.01% | 597 |
|
|
2022
Q4 | $1.84M | Sell |
16,251
-105
| -0.6% | -$11.9K | 0.02% | 376 |
|
|
2022
Q3 | $1.32M | Buy |
16,356
+3,573
| +28% | +$288K | 0.01% | 420 |
|
|
2022
Q2 | $953K | Buy |
12,783
+7,107
| +125% | +$530K | 0.01% | 505 |
|
|
2022
Q1 | $726K | Buy |
5,676
+144
| +3% | +$18.4K | 0.01% | 615 |
|
|
2021
Q4 | $743K | Buy |
5,532
+104
| +2% | +$14K | ﹤0.01% | 636 |
|
|
2021
Q3 | $742K | Buy |
5,428
+920
| +20% | +$126K | 0.01% | 612 |
|
|
2021
Q2 | $481K | Buy |
4,508
+2,248
| +99% | +$240K | ﹤0.01% | 656 |
|
|
2021
Q1 | $203K | Sell |
2,260
-44
| -2% | -$3.95K | ﹤0.01% | 757 |
|
|
2020
Q4 | $213K | Buy |
2,304
+184
| +9% | +$17K | ﹤0.01% | 732 |
|
|
2020
Q3 | $218K | Buy |
2,120
+20
| +1% | +$2.06K | ﹤0.01% | 658 |
|
|
2020
Q2 | $213K | Buy |
+2,100
| New | +$213K | ﹤0.01% | 625 |
|